Volume 57, Issue 1, Pages (January 2000)

Slides:

Advertisements

Similar presentations

Chapter 1: Definition and classification of CKD Kidney International Supplements Volume 3, Issue 1, Pages (January 2013) DOI: /kisup

Advertisements

Steven Fishbane, Jeffrey S. Berns, M.D. Kidney International

Beta blockers in the management of chronic kidney disease

Tuberculosis and tubulointerstitial nephritis: an intriguing puzzle

Volume 70, Pages S38-S43 (November 2006)

David J. Tunnicliffe, Suetonia C. Palmer

John P. Middleton, Patrick H. Pun Kidney International

Volume 77, Issue 1, Pages 6-8 (January 2010)

Erratum American Journal of Kidney Diseases

Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Sanjeev Kumar, Stanley L.-S. Fan, Martin.

Jeffrey C. Fink, Glenn M. Chertow Kidney International

Volume 69, Issue 2, Pages (January 2006)

Volume 92, Issue 1, Pages (July 2017)

Iva Gunnarsson, MD, PhD American Journal of Kidney Diseases

Comorbidity and confounding in end-stage renal disease

Volume 71, Issue 6, Pages (March 2007)

Volume 70, Issue 11, Pages (December 2006)

D. Coyne Kidney International Volume 69, Pages S1-S3 (May 2006)

Volume 77, Issue 2, Pages (January 2010)

Volume 87, Issue 1, Pages (January 2015)

The analysis of survival data: the Kaplan–Meier method

Body size and outcomes on peritoneal dialysis in the United States

The Case ∣ Fever, rash, and positive Ehrlichia antibodies

Volume 67, Issue 1, Pages (January 2005)

Volume 70, Issue 8, Pages (October 2006)

Fructose intake as a risk factor for kidney stone disease

Volume 73, Issue 12, Pages (June 2008)

Volume 87, Issue 1, Pages (January 2015)

Günter Weiss, Florian Kronenberg Kidney International

Volume 89, Issue 5, Pages (May 2016)

The third World Kidney Day: Looking back and thinking forward

Volume 82, Issue 10, Pages (November 2012)

Volume 66, Issue 2, Pages (August 2004)

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Tilman B. Drüeke, Ziad A. Massy Kidney International

Abdulla K. Salahudeen, Erwin H. Fleischmann, John D. Bower

Alternate-day dialysis may be needed for hemodialysis patients

Volume 93, Issue 1, Pages (January 2018)

Volume 85, Issue 1, Pages 3-4 (January 2014)

Simvastatin in nephrotic syndrome

Nephrology Crossword: Glomerulonephritis

Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis N.-Y. Zalunardo, C.-L. Rose, I.W.Y.

Volume 71, Issue 12, Pages (June 2007)

Volume 78, Issue 5, Pages (September 2010)

Quality of life in peritoneal dialysis patients: Decline over time and association with clinical outcomes Sr. Anne B. Bakewell, Rob M. Higgins, Mair.

Volume 73, Issue 9, Pages (May 2008)

Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients B. Bammens, P. Evenepoel, H. Keuleers,

Daily nocturnal home hemodialysis

Racial differences in survival of patients on dialysis

Organ transplantation goes to the movies

Low triiodothyronine and survival in end-stage renal disease

Volume 72, Issue 3, Pages (August 2007)

Volume 70, Issue 8, Pages (October 2006)

Class IV-S versus class IV-G lupus nephritis: Clinical and morphologic differences suggesting different pathogenesis Gary S. Hill, Michel Delahousse,

Robert G. Nelson, Hal Morgenstern, Peter H. Bennett

Charles A. Herzog Kidney International

Volume 70, Issue 3, Pages (August 2006)

Volume 70, Issue 5, Pages (September 2006)

Volume 75, Issue 7, Pages (April 2009)

Volume 70, Issue 3, Pages (August 2006)

Volume 82, Issue 9, Pages (November 2012)

Volume 72, Issue 11, Pages (December 2007)

The International Pediatric Peritonitis Registry: Starting to walk

Volume 69, Issue 8, Pages (April 2006)

Volume 57, Issue 2, Pages (October 2000)

Stephen Pastan, J. Michael Soucie, William M. McClellan

Sugar-sweetened beverages and chronic disease

Volume 77, Issue 2, Pages (January 2010)

Volume 60, Issue 1, Pages (July 2001)

Presentation transcript:

Volume 57, Issue 1, Pages 258-264 (January 2000) Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide John P.A. Ioannidis, Kyriaki A. Boki, Maria E. Katsorida, Alexandros A. Drosos, Fotini N. Skopouli, John N. Boletis, Haralampos M. Moutsopoulos, M.D. Kidney International Volume 57, Issue 1, Pages 258-264 (January 2000) DOI: 10.1046/j.1523-1755.2000.00832.x Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 1 Kaplan–Meier curves for (A) the time to remission after the start of intravenous cyclophosphamide (IVC; N = 85), (B) the time to relapse after remission (N = 63 with remission), and (C) the time to re-remission after relapse (N = 23 with relapse). Each patient censored without an event is shown by a cross in the Kaplan–Meier curves. The number of patients at risk and the cumulative number of events at 0, 20, 40, 60, 80, and 100 months are also shown under each Kaplan–Meier plot. Kidney International 2000 57, 258-264DOI: (10.1046/j.1523-1755.2000.00832.x) Copyright © 2000 International Society of Nephrology Terms and Conditions